This work was supported by grants from the National Natural Science Foundation of China (81671250,82071420,82101333,81870997,82171251);Jiangsu Provincial Key R&D Program (BE2018658);the Key Project of Natural Science Foundation of Jiangsu Provincial Higher Education Institutions (21KJA180003);the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD).
Inflammation is one of the pathogenic processes in Parkinson’s disease(PD).Dopamine receptor agonist pramipexole(PPX)is extensively used for PD treatment in clinics.A number of studies show that PPX exerts neuroprote...